Patients eligible for , or receiving , step @ or step @ combination therapy per National Heart , Lung , and Blood Institute guidelines , received ICS plus either once-daily tiotropium ( n = @ ) or twice-daily LABAs ( n = @ , ) and were followed up for up to @ months .